Glanbia plc Half Year 2020 Results presentation
Group Managing Director Group Finance Director
Glanbia plc Half Year 2020 Results presentation Group Managing - - PowerPoint PPT Presentation
Glanbia plc Half Year 2020 Results presentation Group Managing Director Group Finance Director 2 Glanbia plc | Half Year 2020 presentation Important notice This presentation contains forward-looking statements. These statements have been
Group Managing Director Group Finance Director
This presentation contains forward-looking statements. These statements have been made by the Directors in good faith based on the information available to them up to the time of their approval of this presentation. Due to the inherent uncertainties, including both economic and business risk factors underlying such forward-looking information, actual results may differ materially from those expressed or implied by these forward- looking statements. The Directors undertake no obligation to update any forward-looking statements contained in this presentation, whether as a result of new information, future events, or otherwise.
Important notice
Glanbia plc | Half Year 2020 presentation 2Strong position from outset of the crisis
Glanbia plc | Half Year 2020 presentation 3Covid-19 – Delivering against our priorities
Protecting
Maintaining food supply Maintain financial position
Managed health and safety
Maintained production across the Group throughout the crisis Net debt: Adjusted EBITDA 1.95x
Evolving market dynamics
Glanbia plc | Half Year 2020 presentation 4Customers Consumers Our Communities
wellness brands and ingredients
brands in performance nutrition and weight management
demographics
ecommerce and decline of specialty channels in GPN
assortment and shelf space
ingredients
multiple examples of community support across the Group
health and wellbeing of employees paramount
management meant no drawdowns of Governmental supports
Portfolio well positioned
Q1 Apr May Jun Jul
GPN YoY revenue progression 2020
Implications for Glanbia in H1 2020
Glanbia plc | Half Year 2020 presentation 5Joint Ventures –
demand good
Sports & Lifestyle Nutrition Supplements/ Immunity Fortified Food & Beverage Specialised Nutrition US Cheese
Significant volatility in Q2 International & North America Specialty channel primary drivers of decline Improving trends into H2 New JV projects
Trends improving Resilient through Covid-19
Our strategy is aligned to the new environment
Glanbia Performance Nutrition Glanbia Nutritionals Group
ON and SlimFast brands
route-to-market & supply chain
key platforms
adjacencies - Foodarom acquisition
deployment policy
to navigate crisis
working to new environment
new forms of engagement
for health & wellness products
International business
demand & productivity
Existing strategy
Covid-19 response
Glanbia structured well to capture opportunities
Glanbia plc | Half Year 2020 presentation 7Trends driving our business have grown more powerful
Health and wellness Digital Our Categories
Brand in performance nutrition & Brand in weight management in the US ON & SlimFast
Producer of protein solutions for convenient nutrition category in US Essential micro nutrients ingredients supplier Globally Protein category resilient Weight management in growth Immune enhancing ingredients and brands very ‘on-trend’ Reduced ‘food-to-go’ demand Food staples demand strong
Now in markets + hosting ON DTC websites
€620.1m 1.7% (14.9%) (0.7%) €532.4m
HY19 FX Volume Price HY20
Revenue progression
North America Performance Nutrition
channels offset by weak specialty and distributor channels in Q2
North America Lifestyle
from SlimFast and Amazing Grass
International
DTC
teams now servicing 10 markets
EBITA
GPN Half Year review
Glanbia plc | Half Year 2020 presentation 9€19.6m
EBITA
3.7%
MARGIN
*RTE – ready-to-eatImproving trends and margins into Q3
GPN transformation focused on revenue and margin growth
Glanbia plc | Half Year 2020 presentation 10International route-to-market Revenue growth management Channel focus Brand focus Supply chain Productivity Global footprint SKUs and contract exit
Demand Efficiency
Portfolio streamlined – 35% of SKUs removed and ON & SlimFast now 69% of sales GPN reorganised into 4 focus areas New RTM partners in place in International markets NA Contract exit on track Scope increased as a result
demand & productivity leveraging FDMC & online acceleration
Supply chain consolidation underway
Targeting EBITA margins of 12% to 13% by 2022
Significant position in growth channels – online and FDMC
Glanbia plc | Half Year 2020 presentation 11Revenue by channel
FDMC 34% Online 26% Distributors 20% Specialty 20% FDMC 40% Online 34% Distributors 12% Specialty 14%
Channel HY 20 Growth* FDMC +1% Online +11% Distributors (46%) Specialty (41%)
*Reported currency
North America Performance Nutrition 38% North America Lifestyle 29% International 27% DTC 6% North America Performance Nutrition 37% North America Lifestyle 35% International 21% DTC 7%
GPN has a scale business in North America
Glanbia plc | Half Year 2020 presentation 12Market HY 20 Growth NA PN* (11%) NA Lifestyle +2% International (33%) DTC (5%)
*LFL Branded
Revenue by market
due to challenging Q2
trend sequentially improving during Q2
in the specialty and distributor channels which impacted branded and contract sales
in FDM and consumption trends improved at the end of Q2
and club versus specialty
North America Performance Nutrition
Glanbia plc | Half Year 2020 presentation 13ON net promoter score increased and is the highest in the category
growing presence online
which stabilised by the end of the period
long as mobility in NA remains below normal levels
management (SlimFast) as well as natural immunity (Amazing Grass)
North America Lifestyle
Glanbia plc | Half Year 2020 presentation 14Brand awareness Household penetration up 60 bps to 5.0%
98%
leverage in H1
complete with clear brand focus, new team and new in-market partners in certain regions
aim is to right size the organisation to the opportunity, scaling back footprint in certain markets while leveraging ecommerce capability across all markets
International
Glanbia plc | Half Year 2020 presentation 15in H1
market as a result of gym closures
markets in Europe and RoW
management of ON brand DTC website
DTC – eCommerce opportunity
Glanbia plc | Half Year 2020 presentation 16DTC Brand.com
Russia Sweden Portugal Italy France Spain UK Germany Poland BeneluxExisting markets New markets entered in 2020
Glanbia Nutritionals Half Year review
Glanbia plc | Half Year 2020 presentation 18+12.0% cc
€1,304.3m
REVENUE
€65.4m
EBITA
5.0%
MARGIN
Resilient performance in H1
€369.6m 2.0% 1.2% (1.8%) 3.5% €387.9m
HY19 FX Volume Price Acquisition HY20
Revenue progression Non-dairy Ingredients
Covid-19
Dairy Ingredients
Watson
February 2019
EBITA
demand
product mix
Nutritional Solutions Half Year review
Glanbia plc | Half Year 2020 presentation 19€48.1m
EBITA
12.4%
MARGIN
Essential Micro Nutrients
and value-added protein ingredients
brand owners in categories across mainstream food & beverage and specialised nutrition and supplements
Nutritional Solutions Strategy
Glanbia plc | Half Year 2020 presentation 20Core Solutions Providing the building blocks for our customers’ brands in the following categories
Supplements Clinical Nutrition Early Life Nutrition Performance Nutrition Lifestyle Nutrition
Protein Ingredients
Glanbia has agreed to acquire ‘Foodarom’, a c.CAD 34m revenue flavors business based in Montreal, Canada
Foodarom acquisition announcement
Glanbia plc | Half Year 2020 presentation 21Foodarom has a strong flavor formulation capabilityand is focused
Foodarom has manufacturing and applications facilities in Canada, the US and Europe Foodarom is scalable and will enable the further development of flavor solutions within NS Expected to complete in H2 2020 subject to the customary closing conditions and be earnings accretive from 2021 Purchase price is CAD 60m plus contingent consideration
Description Strategic rationale Transaction details
€768.7m 2.5% 6.0% 10.3% €916.4m
HY19 FX Volume Price HY20
Revenue progression
US Cheese Half Year review
Glanbia plc | Half Year 2020 presentation 22+20.1% cc
€17.3m
EBITA +10 bps
1.9%
MARGIN
Volumes
customers with retail end markets
Pricing
Operations
plants which improved margin
EBITA
Joint Ventures Half Year review
Glanbia plc | Half Year 2020 presentation 23Revenue*
+17.3% cc
Share of PAT**
JV business model
unprecedented volatility
Revenue
Profitability
New JV projects
Mark Garvey
Group Finance Director
Net debt to adjusted EBITDA 1.95 times Wholly-owned Revenue growth of 2.3%, constant currency Adjusted EPS down 17.2% constant currency due to Covid- 19 related disruption Strong performance by Glanbia Nutritionals offset by Q2 weakness in GPN Interim dividend payment of 10.68c cent GN & JVs continue to be resilient Good operating cash flow performance GPN improving after challenging Q2 with strategic initiatives
HY 2020 – Resilient performance in a challenging environment
Glanbia plc | Half Year 2020 presentation 25Growth Earnings Cash & Debt Dividends Current trading
GPN International disruption primary impact on earnings Dividend payout ratio 34%
HY 2020 results summary pre-exceptional €'m Reported currency Constant currency
HY 2020 HY 2019 Change Change Revenue (Wholly-owned) 1,836.7 1,758.4 4.5% 2.3% EBITA (Wholly-owned) 85.0 111.4 (23.7%) (25.4%) EBITA margin 4.6% 6.3%
Amortisation (30.5) (28.9) Net Finance Costs (11.5) (13.3) Share of Joint Ventures 31.8 26.8 Income Tax (4.9) (9.2) Profit for the period (pre-exceptional) 69.9 86.8 Adjusted EPS 31.05c 36.69c (15.4%) (17.2%) Basic EPS 18.73c 28.22c
Half Year Group Income Statement
Glanbia plc | Half Year 2020 presentation 26International
by negative operating leverage in GPN due to Covid-19 impact
and other incidental costs
Exceptional Items HY 2020 HY 2019
€‘m €‘m Reorganisation costs 15.2 3.2 Covid-19 costs 3.5
(3.5)
Exceptional charge before tax 15.2 4.3 Share of results of Joint Venture – Covid-19 costs 1.2
(1.8) (0.8) Total exceptional charge after tax 14.6 3.5
Exceptional Items
Glanbia plc | Half Year 2020 presentation 27Strong Cash Flow enabling investment & returns
€47m
OCF improved by €28 million Operated to plan across the Group throughout the crisis FY20 capex expected to be in the €65m to €75m range
€18m
Total capex
€29m
10.68c
Operating Cash Flow Dividends from JVs Capital Expenditure Interim Dividend Targeting +80% OCF conversion for FY20 Dividend payout 34%
Improving Balance Sheet
Glanbia plc | Half Year 2020 presentation 29the Covid-19 pandemic
to strong cash generation
be drawn down in December 2020
Foodarom for CAD 60m
€1.1 billion
Balance Sheet KPIs HY 2020 HY 2019
Net Debt €651m €778m
Net Debt / Adj. EBITDA 1.95x 2.14x
9.4x 10.5x
Siobhán Talbot
Group Managing Director
Conclusions
Glanbia plc | Half Year 2020 presentation 31Non-IFRS performance measure definitions
Glanbia plc | Half Year 2020 presentation 34The Group reports certain performance measures that are not defined under IFRS but which represent additional measures used by the Board of Directors and the Glanbia Operating Executive in assessing performance and for reporting both internally and to shareholders and other external users. The Group believes that the presentation of these non-IFRS performance measures provides useful supplemental information which, when viewed in conjunction with our IFRS financial information, provides readers with a more meaningful understanding of the underlying financial and operating performance of the Group.
effect of foreign exchange on the Group's results. To arrive at the constant currency period-on-period change, the results for the prior year are retranslated using the average exchange rates for the current year and compared to the current period reported numbers
Group’s operations. Total Group is used to describe certain financial metrics such as Revenue and EBITA when they include both the wholly-owned businesses and the Group's share of equity accounted investees
purchased by the Group and held as own shares
the weighted average number of ordinary shares in issue during the period. The Group believes that adjusted EPS is a better measure of underlying performance than Basic EPS as it excludes exceptional items (net of related tax) that are not related to ongoing operational performance and intangible asset amortisation, which allows better comparability of companies that grow by acquisition to those that grow organically
accordance with lenders’ facility agreements definition which adjust pre-exceptional EBITDA for items such as dividends received from Equity accounted investees, acquisitions or disposals and to reverse the net impact on EBITDA as a result of adopting IFRS 16 ‘Leases’. Adjusted EBITDA is a rolling 12 month measure, therefore for half year 2020 and half year 2019 it is calculated as the Adjusted EBITDA for the preceding 12 months ending on the relevant reporting dates
Net finance cost comprises finance costs less finance income per the Condensed Group income statement plus capitalised borrowing costs and excludes Interest expense on lease liabilities. Adjusted EBIT and net finance cost are rolling 12 month measures, therefore for half year 2020 and half year 2019 are calculated as the Adjusted EBIT and net finance costs for the preceding 12 months
Non-IFRS performance measure definitions
Glanbia plc | Half Year 2020 presentation 35financial position of the Group. Determining which transactions are to be considered exceptional in nature is often a subjectivematter. However, circumstances that the Group believes would give rise to exceptional items for separate disclosure are outlined in the accounting policy on exceptional items in note 2 to the financial statement in the 2019 financial statements
impact of sales pricing (including trade spend) within revenue movement period-on-period, excluding acquisitions, on a constant currency basis
Group’s current competitive position.
calculated as the net cash flow in the period before the following items: strategic capital expenditure, proceeds received ondisposals, loans to / investments in equity accounted investees, equity dividends paid, exceptional costs paid, acquisition spend and currency translation movements
capacity for a bigger business. It enables the Group to keep running at current throughput rates but also keep pace with regulatory and environmental changes as well as complying with new requirements from existing customers
Group’s current competitive position
Group’s working capital management programme
returned to shareholders relative to the Group's total earnings
Adjusted EPS
Glanbia plc | Half Year 2020 presentation 36€’m Reported currency Constant currency
Adjusted EPS
HY 2020 HY 2019 HY 2019
Profit attributable to equity holders of the Company 55.3 83.3 85.1 Exceptional Items 14.6 3.5 3.6 Profit attributable to equity holders of the Company - pre-exceptional 69.9 86.8 88.7 Amortisation (net of tax)* 21.8 21.5 22.0 Adjusted net income 91.7 108.3 110.7 Weighted average number of ordinary shares in issue (millions) 295.3 295.2 295.2 Adjusted Earnings Per Share (cent) 31.05 36.69 37.50 Constant currency growth
*Amortisation and impairment of intangible assets (excluding software amortisation) net of related tax of €3.7 million (HY 2019: €3.9 million, 2019: €8.1 million)
Segmental Analysis
Glanbia plc | Half Year 2020 presentation 37€’m Reported currency Constant currency
Glanbia Performance Nutrition
HY 2020 HY 2019 HY 2019 Growth %
Revenue 532.4 620.1 630.6
EBITA 19.6 46.9 47.9
EBITA margin 3.7% 7.6% 7.6%
€’m Reported currency Constant currency
Glanbia Nutritionals
HY 2020 HY 2019 HY 2019 Growth %
Revenue* 1,304.3 1,138.3 1,165.0 12.0% EBITA 65.4 64.5 66.0
EBITA margin 5.0% 5.7% 5.7%
*As a result of the adoption of IFRS 15 in 2019, Revenue in Glanbia Nutritionals includes 100% of revenue from the Southwest Cheese joint venture. All comparisons are on a like-for-like basis
Segmental Analysis
Glanbia plc | Half Year 2020 presentation 38€'m Reported currency Constant currency
Nutritional Solutions
HY 2020 HY 2019 HY 2019 Growth %
Revenue* 387.9 369.6 376.9 2.9% EBITA 48.1 50.5 51.6
EBITA margin 12.4% 13.7% 13.7%
€'m Reported currency Constant currency
US Cheese
HY 2020 HY 2019 HY 2019 Growth %
Revenue* 916.4 768.7 788.1 16.3% EBITA 17.3 14.0 14.4 20.1% EBITA margin 1.9% 1.8% 1.8% +10 bps
*As a result of the adoption of IFRS 15 in 2019, Revenue in Glanbia Nutritionals (Nutritional Solutions & US Cheese) includes 100% of revenue from the Southwest Cheese joint venture. All comparisons are on a like-for-like basis
Segmental Analysis
Glanbia plc | Half Year 2020 presentation 39€'m Reported currency Constant currency
Revenue
HY 2020 HY 2019 HY 2019 Growth %
Glanbia Performance Nutrition 532.4 620.1 630.6
Nutritional Solutions 387.9 369.6 376.9 2.9% US Cheese 916.4 768.7 788.1 16.3% Glanbia Nutritionals* 1,304.3 1,138.3 1,165.0 12.0% Wholly-owned Revenue 1,836.7 1,758.4 1,795.6 2.3%
*As a result of the adoption of IFRS 15 in 2019, Revenue in Glanbia Nutritionals includes 100% of revenue from the Southwest Cheese joint venture. All comparisons are on a like-for-like basis
Segmental Analysis
Glanbia plc | Half Year 2020 presentation 40€'m Reported currency Constant currency EBITA HY 2020 HY 2019 HY 2019 Growth %
Glanbia Performance Nutrition 19.6 46.9 47.9
Nutritional Solutions 48.1 50.5 51.6
US Cheese 17.3 14.0 14.4 20.1% Glanbia Nutritionals 65.4 64.5 66.0
Wholly-owned EBITA 85.0 111.4 113.9